So-Young International Inc.

NASDAQ:SY

Medical - Healthcare Information Services

Healthcare
$1.83 -5.83%

-$0.09 today

Market cap
$239.36M
Beta
1.98
P/E (TTM)
-5.0
EPS (TTM)
-$1.95
52W Low $1.00High $6.28

Volume 0.46M

Average 0.63M

SY Revenue

Total income from selling goods and services before any costs are deducted; the top line of the income statement.

So-Young International Inc.NASDAQ: SY

Revenue · Q1 FY2026 · quarter ended Mar 2026

Revenue growth accelerates

Q1 FY2026 revenue of CN¥430.16M rose 44.7% year over year, ahead of the +14.1% change in trailing-twelve-month revenue. Sequentially, it fell 5.3% from the prior quarter. Over 3 fiscal years it compounded at +5.6% a year.

Context

  • Revenue increased in 2 of the last 3 fiscal years.

What to watch

Whether revenue reaches the consensus estimate from 2 analysts of CN¥2.06B (+39.1%) for the fiscal year ending Dec 2026, a step up from the +1.0% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
CN¥430.16M-5.3% QoQ
Last fiscal yearDec 2025
CN¥1.48B+1.0% YoY
LTMMar 2026
CN¥1.65B+14.1% YoY
Revenue past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+44.7%+26.2%-18.5 pp
1 year+1.0%+39.1%+38.1 pp
3-year CAGR+5.6%+35.2%+29.6 pp
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Revenue history

CNY · from the income statement

Latest · FY2025
1.48B CNY
Year-over-year change
+1.0%
4-year CAGR
-3.3%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Revenue vs competitors

How SY compares with its peers on the latest reported figures

  • Peers report in different currencies, so revenue is compared through growth and rates rather than absolute size.
  • Its year-over-year change of +14.1% is the 4th highest of 8, against a peer median of +4.4%.
  • Over three fiscal years its annual growth of +5.6% compares with a peer median of +13.7%.
SY Competitors
Revenue for SY and competitors
Company Period LTM YoY 3-year CAGR
SYSo-Young International Inc.LTM Mar 2026CN¥1.65B CNY+14.1%+5.6%
VREXVarex Imaging CorporationLTM Apr 2026$857.5M USD+3.6%-0.6%
SNDASonida Senior Living, Inc.LTM Mar 2026$411.85M USD+25.3%+16.9%
LABStandard BioTools Inc.LTM Mar 2026$86.26M USD-35.8%-4.5%
SOPHSOPHiA GENETICS S.A.LTM Mar 2026$81.18M USD+20.9%+17.6%
SLPSimulations Plus, Inc.LTM Feb 2026$80.54M USD+2.5%+13.7%
ADCTADC Therapeutics S.A.LTM Mar 2026$79.18M USD+4.4%-27.1%
LXRXLexicon Pharmaceuticals, Inc.LTM Mar 2026$69.64M USD+123.1%+610.3%
OMEROmeros CorporationLTM Mar 2026$9.89M USD——
CGEMCullinan Therapeutics, Inc.LTM Mar 2026$0 USD——
NMRANeumora Therapeutics, Inc. Common StockLTM Mar 2026$0 USD——
Peer median (excluding SY) —+4.4%+13.7%

Competitors are the stored peer set for SY. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

CNY
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue1.69B1.26B1.5B1.47B1.48B
Cost of Revenue327.89M393.29M544.34M567.59M774.04M
Gross Profit1.36B864.58M953.69M899.11M707.86M
Gross Margin80.6%68.7%63.7%61.3%47.8%
Research & Development286.57M235.09M203.52M165.03M133.31M
Selling, General & Admin1.04B732.3M811.22M818.57M833.76M
Operating Expenses1.4B967.39M1.01B1.52B967.07M
Depreciation & Amortization30.08M47.09M46.09M46.09M57.21M
EBITDA63.39M(39.99M)53.96M(38.39M)(182.19M)
EBITDA Margin3.7%-3.2%3.6%-2.6%-12.3%
Operating Income(32.57M)(102.81M)(61.05M)(624.49M)(259.21M)
Operating Margin-1.9%-8.2%-4.1%-42.6%-17.5%
Interest Income19.33M28.88M48.84M46.51M24.6M
Interest Expense00000
Other Income / Expenses16.17M15.73M68.92M36.41M19.8M
Income Before Tax(16.41M)(87.07M)7.87M(588.09M)(239.4M)
Pre-Tax Margin-1.0%-6.9%0.5%-40.1%-16.2%
Income Tax Expense21.23M(20.97M)(18.08M)(905K)(774.31K)
Net Income(8.37M)(65.55M)21.28M(589.53M)(235.7M)
Net Margin-0.5%-5.2%1.4%-40.2%-15.9%
EPS (Basic)(0.06)(0.48)0.16(4.40)(1.78)
EPS (Diluted)(0.06)(0.48)0.16(4.39)(1.78)
Weighted Avg Shares138.04M138.04M133.19M134.09M131.59M
Weighted Avg Shares (Diluted)138.04M138.04M131.91M134.16M131.59M

So-Young International Inc.

NASDAQ:SY

Intrinsic Alpha fair value

Locked

Current Price

$1.83

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.